Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency
HL Malech, DD Hickstein - Current opinion in hematology, 2007 - journals.lww.com
HL Malech, DD Hickstein
Current opinion in hematology, 2007•journals.lww.comThe most important subjects reviewed in this chapter include new advances in development
of gene therapy for chronic granulomatous disease and leukocyte adhesion deficiency-I;
transplantation for leukocyte adhesion deficiency-I; prenatal diagnosis of leukocyte
adhesion deficiency-I; and association of autoimmune diseases with chronic granulomatous
disease.
of gene therapy for chronic granulomatous disease and leukocyte adhesion deficiency-I;
transplantation for leukocyte adhesion deficiency-I; prenatal diagnosis of leukocyte
adhesion deficiency-I; and association of autoimmune diseases with chronic granulomatous
disease.
Summary
The most important subjects reviewed in this chapter include new advances in development of gene therapy for chronic granulomatous disease and leukocyte adhesion deficiency-I; transplantation for leukocyte adhesion deficiency-I; prenatal diagnosis of leukocyte adhesion deficiency-I; and association of autoimmune diseases with chronic granulomatous disease.
Lippincott Williams & Wilkins